Amsel Medical specializes in innovative surgical technologies, particularly the SCureClamp™ with Interdigitation Occlusion Technology (iDOT™). This device is designed for secure closure of various tubular structures, including veins and arteries, during surgical procedures. The SCureClamp is delivered through a minimally invasive 18 G needle, allowing for effective occlusion that mimics the results of traditional transfixion sutures. Its unique mechanical clamping mechanism ensures that the implant remains securely in place, reducing the risk of slippage and accommodating vessels of different sizes and wall thicknesses. The technology is CE marked and FDA cleared, indicating its safety and efficacy for use in open general surgery.

In addition to its applications in vascular surgery, the SCureClamp is also being developed for military trauma care, addressing the critical need for effective tools to manage non-compressible hemorrhage in prehospital environments. Amsel Medical's commitment to advancing surgical techniques is further supported by peer-reviewed studies demonstrating the device's effectiveness in various surgical contexts, including laparoscopic procedures. The SCureClamp represents a significant advancement in surgical occlusion technology, offering a reliable and efficient alternative to traditional ligation methods, thereby enhancing patient outcomes and reducing complications associated with vein diseases and trauma.

United States

This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture.

SCureClamp with iDOT's anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types, and wall thickness.

Amsel Medical

Company Details